Investment opportunities in the medical industry

How to adjust the new national medical insurance catalog? Here is the explanation.

cls.cn · Nov 28, 2024 08:54

HKD 5.4 billion! 30% premium for privatization!

Securities Times · Jun 24, 2024 23:20

Investment in expanding production has seen initial results! The supply shortage of Eli Lilly and Co in Japan has been alleviated, and the shipping control has been finally lifted.

Zhitong Finance · Jun 6, 2024 01:33

Did the big reversal cause the stock price to skyrocket? Kangfang Biotech's “head-to-head” efficacy is better than K medicine. Industry: bullets need to fly a little longer

cls.cn · May 31, 2024 05:54

Bad raid! This pharmaceutical stock once plummeted 58%!

券商中國 · May 29, 2024 02:21

There were two fires in a week! Novo Nordisk says diet drug production capacity has not been affected

cls.cn · May 22, 2024 11:05

The 40-1 ratio is huge! The new version of the US House of Representatives “Biosafety Act” was passed in a hearing. The industry suggests paying attention to the subsequent run-in between the two house versions of the bill

cls.cn · May 15, 2024 23:15

Beijing has brought great benefits to innovative drugs!

券商中國 · Apr 8, 2024 03:52

MSD's major new drug for pulmonary hypertension was approved, priced at $14,000 per bottle

cls.cn · Mar 27, 2024 08:52

“Weight loss elixir” can cure kidney disease. Why is Novo Nordisk's stock price not rising but falling?

cls.cn · Mar 5, 2024 19:53

As diet pills continue to be “hot and hot,” Goldman Sachs boldly predicts that it will increase US GDP by 1% in the next few years!

Zhitong Finance · Feb 22, 2024 19:21

More than just “weight loss elixir” analysts are optimistic that Eli Lilly's market capitalization will hit 1 trillion US dollars

cls.cn · Feb 18, 2024 02:25

Who wouldn't want to be the next Jia Ling? Supply is in short supply, and the expansion of production of the “Weight Loss Duo” is progressing smoothly

wallstreetcn · Feb 11, 2024 04:16

Hong Kong Stock Concept Tracking | Pharmaceutical companies' pricing is being loosened? The innovative drug sector is expected to usher in a beta market (with concept stocks)

Zhitong Finance · Feb 6, 2024 19:35

The number of new drugs approved by the US FDA jumped 50% last year. Can biomedical concept stocks continue to benefit?

cls.cn · Jan 3, 2024 05:23

Piper Sandler Announces 2024 Biotech Stock Preferred List!

Golden10 Data · Dec 29, 2023 09:21

AstraZeneca acquires Chinese cancer drug developer with a deal value of about US$1.2 billion

cls.cn · Dec 26, 2023 06:42

Eli Lilly's tilpotide is expected to become the strongest “weight loss drug”. Agency: Expected sales volume to reach 27 billion US dollars in 2029

Zhitong Finance · Dec 25, 2023 05:44

Hamena broke a new high in the reversal market. How did the US health insurance giant, 25 times larger in 25 years, get through the economic bulls and bears?

Column · Sep 21, 2022 04:36

Cell and gene therapy CDMO is expected to become a tenfold investment circuit in the next ten years

專欄 · Jul 9, 2021 05:46

The market is buzzing about the new anti-tumor drug regulations. What does this mean for the booming CXO industry?

華爾街見聞 · Jul 4, 2021 19:31

Investment strategy for the second half of 2021: sector mining, close to the main “consumption+innovation” investment line

專欄 · Jun 30, 2021 04:58

The arrival of the COVID-19 vaccine is a big plus! The Moderna vaccine produced antibodies to the “Delta” strain, and the stock price soared to a record high

Bloomberg · Jun 29, 2021 20:22

570 billion vaccine giants are frantically expanding production. What are the signs? The epidemic revealed two major differences in expectations. Has the vaccine pattern changed?

券商中國 · Jun 22, 2021 21:21